Health In Her HUE, a digital platform connecting Black women to culturally sensitive healthcare providers, has announced a new partnership with pharmaceutical company Takeda to improve clinical trial access and representation for underserved communities.
The collaboration will give Health In Her HUE’s community access to WeConnect, Takeda’s patient registry platform designed to help people find and connect with clinical trials that match their specific health needs. WeConnect simplifies the process of discovering relevant clinical trials by allowing users to register their health interests and receive personalized notifications about potential research opportunities.
“Equity in healthcare starts with inclusion in research. Our partnership with Takeda and the WeConnect platform is a step toward making clinical trials more accessible, ensuring that Black women and other underrepresented communities have a seat at the table,” said Princess Uzoh, Head of Sales at Health In Her HUE.
This initiative addresses a significant gap in clinical research, where Black women and other minorities have historically been underrepresented. The lack of diversity in clinical trials has led to treatment protocols and medications that may not be equally effective across all populations, contributing to healthcare disparities.
Through WeConnect, users can explore Takeda clinical trials across various health conditions including psoriasis, narcolepsy, celiac disease, alpha-1 antitrypsin deficiency (AATD), and inflammatory bowel disease (IBD). The platform aims to make the clinical trial journey less intimidating by providing transparent information and personalized matches.
This partnership represents part of a broader effort to diversify clinical trials and ensure that medical advancements benefit all communities equitably. By increasing participation of Black women in clinical research, Health In Her HUE and Takeda hope to contribute to more inclusive healthcare outcomes and reduce disparities in treatment efficacy.